Nasogastric Tube Market Report
RA00740
Nasogastric Tube Market by Patient Type (Adult, Pediatric, and Geriatric), Indication (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, and Others), Type (Small-bore Feeding Tubes and Large-bore Feeding Tubes), End-Use (Hospitals & Nursing Homes and Home Care), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Nasogastric Tube Overview
A nasogastric tube (NG tube) is a flexible medical device inserted through the nose and down the esophagus into the stomach. It is made of rubber or silicone and serves various purposes in medical environments. The tube can feed patients who cannot consume food orally, delivering liquid nutrition or medications directly to their stomach. It is also utilized for decompression, removing excess air, fluid, or gastric contents from the stomach or intestines to alleviate discomfort and prevent complications. An NG tube is also employed in gastric lavage procedures to flush the stomach with a solution to remove toxins or irritants. Sometimes, it is used to administer medications directly into the stomach. Inserting an NG tube requires the expertise of healthcare professionals to ensure proper placement through the nose, throat, and stomach. However, it is essential to recognize risks and potential complications associated with NG tube usage, such as injury to nasal passages or the esophagus.
Global Nasogastric Tube Market Analysis
The global nasogastric tube market size was $505.16 million in 2022 and is predicted to grow at a CAGR of 5.3%, by generating a revenue of $789.04 million by 2032.
COVID-19 Impact on Global Nasogastric Tube Market
The COVID-19 pandemic has had a notable impact on the nasogastric tube market. The increased demand for respiratory support and enteral feeding in hospitalized COVID-19 patients led to a surge in the need for nasogastric tubes, particularly in intensive care units. However, the market also faced challenges due to disruptions in the global supply chain caused by lockdowns, travel restrictions, and trade barriers. The postponement or cancellation of elective surgeries and non-emergency procedures further affected the demand for nasogastric tubes. Additionally, the economic downturn resulted in financial constraints for healthcare systems, leading to reduced spending on medical supplies. The shift towards remote patient monitoring and alternative feeding methods like PEG tubes also impacted the demand for nasogastric tubes.Overall, the nasogastric tube market experienced fluctuations and adaptations in response to the changing healthcare landscape brought about by the pandemic.
Increasing Prevalence of Gastrointestinal Disorders to Drive the Market Growth
The nasogastric tube market is driven by multiple factors. Firstly, the increasing prevalence of gastrointestinal disorders, such as bowel obstruction and gastroparesis contribute to the demand for nasogastric tubes. Secondly, the growing geriatric population, more susceptible to health conditions requiring nasogastric tube placement, further fuels the nasogastric tube market growth. Additionally, nasogastric lines are widely used in surgical procedures and critical care settings, leading to increased demand as the number of such practices and acute care admissions rises. Technological advancements in nasogastric tube design have improved patient comfort and placement, supporting market expansion. Moreover, the overall increase in healthcare expenditure and improved access to healthcare services drive the demand for nasogastric tubes. Awareness initiatives and education programs for healthcare providers also contribute to the market’s growth by promoting the safe and effective use of nasogastric tubes. Lastly, the presence of multiple manufacturers, product diversification, and competition to develop innovative and cost-effective solutions is further propelling the growth of the nasogastric tube market.
Availability of Alternative Tubes to Restrain the Market Growth
Several factors can restrain the nasogastric tube market. One such factor is the availability of alternative feeding tubes, such as gastrostomy or jejunostomy tubes, which offer advantages in certain medical conditions or patient populations, decreasing the demand for nasogastric tubes. Moreover, the risks and potential complications related to nasogastric tube insertion, including inconvenience, sinusitis, pneumonia, and dislodgement, may discourage healthcare providers from utilizing them, mainly if safer or more suitable alternatives are available. Advancements in enteral feeding strategies, such as minimally invasive techniques for gastrostomy or jejunostomy tube placement, give alternative choices that can restrain the demand for nasogastric tubes. Patient preferences and acceptance also play a role, as some individuals may prefer alternative feeding methods or be hesitant to undergo nasogastric tube placement due to discomfort or invasiveness. The nasogastric tube market may also face restraint from emerging enteral feeding technologies that offer improved patient comfort, ease of use, and reduced complications, potentially replacing or competing with nasogastric tubes. Regulatory and reimbursement factors can also influence the utilization of nasogastric tubes, with changes in regulations or reimbursement policies favoring alternative methods impacting healthcare providers’ decisions.
Technological Advancements in Tubes to Drive Excellent Opportunities
The nasogastric tube market presents several opportunities for growth and development. One key opportunity is the growing geriatric population, with its higher incidence of medical conditions requiring nasogastric tubes, contributing to market expansion. Technological advancements in tube design, materials, and functionality, such as softer and more comfortable tubes with improved imaging capabilities and sensor integration, offer further prospects for market growth and enhanced patient outcomes. The rising adoption of enteral nutrition over parenteral nutrition also fuels the demand for nasogastric tubes. Furthermore, emerging markets present untapped growth potential as healthcare infrastructure improves and patient access to medical interventions increases. The increasing number of hospital admissions and surgeries and the expanding home healthcare sector drive the demand for nasogastric tubes.
Global Nasogastric Tube Market Share, by Patient Type, 2022
The adult sub-segment accounted for the highest market share in 2022. Nasogastric tubes have dominated the market for adult patients due to several key factors. First, their usage is deeply rooted in established medical practice, making healthcare providers comfortable and experienced with their implementation. Second, these tubes offer versatility, as they can be used for various purposes, such as enteral feeding, decompression, medication administration, and diagnostics. Third, their non-invasive nature differentiates them from surgical alternatives like gastrostomy or jejunostomy tubes, reducing risks and complications. Moreover, nasogastric tubes are cost-effective compared to other methods, making them preferable in healthcare systems where financial considerations are significant. Lastly, their long-standing availability and widespread familiarity among healthcare professionals contribute to their continued dominance in the nasogastric tube market.
Global Nasogastric Tube Market Share, by Indication, 2022
The others sub-segment accounted for the highest market share in 2022. The nasogastric tube Market is influenced by various sectors, expanding beyond stomach cancer, esophageal cancer, and IBD (inflammatory bowel disease). Several other industries have dominated this market due to their significant impact. One such sector is gastrointestinal (GI) bleeding, where nasogastric tubes are employed to diagnose the source and extent of bleeding and provide temporary hemostasis or medication administration. Additionally, these tubes are utilized in cases of gastric outlet obstruction to decompress the stomach and alleviate symptoms. Postoperative care also uses nasogastric tubes to drain gastric secretions, prevent nausea and vomiting, and ensure gastrointestinal tract patency after abdominal surgeries. Moreover, these tubes find application in nutritional support for patients who are unable to consume sufficient nutrition orally, especially in malnutrition or anorexia. Intensive care units employ nasogastric tubes to closely monitor critically ill patients' fluid and nutritional status and administer medications. Palliative care settings utilize them for symptom management, while nasogastric tubes also play a role in alleviating bowel obstruction symptoms. These sectors collectively contribute to the market’s demand and utilization of nasogastric tubes, alongside stomach cancer, esophageal cancer, and IBD.
Global Nasogastric Tube Market Share, by Type, 2022
The small-bore feeding tubes sub-segment accounted for the highest market share in 2022. Small-bore feeding tubes have emerged as a dominant force in the nasogastric tube market for several reasons. One key factor is the improved comfort they offer to patients. With their smaller diameter, small-bore tubes reduce the risk of nasal trauma and irritation, making them more appealing to individuals requiring long-term enteral feeding. Additionally, these tubes have been outlined to minimize the hazard of aspiration, a severe complication related to nasogastric tube placement. Their appropriate positioning inside the gastrointestinal tract decreases the probability of gastric contents refluxing into the lungs. Enhanced patient mobility is another advantage of small-bore feeding tubes. Their flexibility and flexibility allow patients to move freely without discomfort or dislodgment. Moreover, these tubes are generally better tolerated by patients as they are thinner and cause less irritation. Advances in tube design, such as tapered tips, radiopaque markers, and multiple exit ports, have further contributed to their popularity.
Global Nasogastric Tube Market Share, by End-Use, 2022
The hospitals & nursing homes sub-segment accounted for the highest market. Hospitals and nursing homes have a significant presence in the nasogastric tube market, mainly due to their crucial role in patient care. These healthcare settings serve as primary locations where patients with diverse medical conditions receive treatment and support. Nasogastric tubes are widely used in hospitals and nursing homes for various purposes, such as feeding, medication administration, decompression, and drainage. The large patient population in these facilities drives the demand for nasogastric tubes. Moreover, hospitals and nursing homes possess the necessary medical expertise, with trained healthcare professionals proficient in the insertion, placement, and maintenance of nasogastric tubes, ensuring patient safety. Compliance with stringent regulatory standards and guidelines is another significant factor, as hospitals and nursing homes must adhere to protocols and procedures for proper management of nasogastric tube usage. Furthermore, the bulk purchasing power of these healthcare institutions enables them to negotiate favorable pricing and terms with suppliers, ensuring a steady supply of nasogastric tubes. Lastly, hospitals' referral networks and nursing homes' reliance on specialized care contribute to their substantial demand for nasogastric tubes.
Global Nasogastric Tube Market Share, by Region, 2022
The North America nasogastric tube market generated the highest revenue in 2022. North America has emerged as a dominant force in the nasogastric tube market due to several factors. Technological advancements have been crucial, with the region at the forefront of medical device innovation. The robust healthcare infrastructure in the United States and Canada and high healthcare expenditure have created a favorable environment for the demand and adoption of nasogastric tubes. Additionally, the aging population in North America has increased the need for medical interventions, including using nasogastric tubes for enteral nutrition and medication administration. The prevalence of chronic diseases in the region has further driven the demand for these tubes. Stringent regulatory standards and quality control measures imposed by regulatory bodies such as the FDA and Health Canada ensure the safety and efficacy of nasogastric tubes, contributing to consumer confidence. Furthermore, the presence of major medical device manufacturers and a competitive market landscape has solidified North America's dominance in the nasogastric tube market.
Competitive Scenario in the Global Nasogastric Tube Market
Investment and agreement are common strategies followed by major market players. One of the leading market players in the industry is QMD. QMD has adopted a holding structure concept, under which different types of businesses will be developed.” The acquisitions announced on September 24, 2019, were crucial in branching into the digital commerce segment while the company further explored dynamic business opportunities in the Chinese market. QMD Marketplace will be a digital start-up marketplace that provides unique B2C services by offering special promotions to its active membership base.
Some of the leading nasogastric tube market players are BD, QMD, Angiplast Pvt. Ltd., Securmed, Vygon, Medtronic, Andersen Products Inc., Cardinal Health, Baihe Medical, and Poly Medicure Limited.
| Aspect | Particulars |
| Historical Market Estimations | 2021 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Patient Type |
|
| Segmentation by Indication |
|
|
Segmentation by Type
|
|
| Segmentation by End-Use
|
|
| Key Companies Profiled |
|
Q1. What is the size of the global nasogastric tube market?
A. The size of the global nasogastric tube market was over $506.26 million in 2022 and is projected to reach $789.04 million by 2032.
Q2. Which are the major companies in the nasogastric tube market?
A. Baihe Medical and Poly Medicure Limited are some of the key players in the global nasogastric tube market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Agreement and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Securmed, Vygon, Medtronic, Andersen Products Inc., and Cardinal Health are the companies investing more on R&D activities for developing new products and technologies.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Nasogastric Tube Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Nasogastric Tube Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Nasogastric Tube Market, By Product
5.1. Overview
5.2 Levin Catheter
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Dobhoff Tube
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Sengstaken-Blakemore Tube
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Others
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Research Dive Exclusive Insights
5.6.1 Market attractiveness
5.6.2 Competition heatmap
-
6. Nasogastric Tube Market, By Application
6.1. Overview
6.2 Hospitals
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Clinics
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Others
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Nasogastric Tube Market, By Testing Type
7.1. Overview
7.2 Pediatric
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Adult
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Dive Exclusive Insights
7.4.1 Market attractiveness
7.4.2 Competition heatmap
8. Nasogastric Tube Market, By Region
8.1 North America
8.1.1 U.S
8.1.1.1 Market size analysis, By Product, 2020-2027
8.1.1.2 Market size analysis, By Application, 2020-2027
8.1.1.3 Market size analysis, By Testing Type, 2020-2027
8.1.2 Canada
8.1.2.1 Market size analysis, By Product, 2020-2027
8.1.2.2 Market size analysis, By Application, 2020-2027
8.1.2.3 Market size analysis, By Testing Type, 2020-2027
8.1.3 Mexico
8.1.3.1 Market size analysis, By Product, 2020-2027
8.1.3.2 Market size analysis, By Application, 2020-2027
8.1.3.3 Market size analysis, By Testing Type, 2020-2027
8.1.4 Research Dive Exclusive Insights
8.1.4.1 Market attractiveness
8.1.4.2 Competition heatmap
8.2 Europe
8.2.1 Germany
8.2.1.1 Market size analysis, By Product, 2020-2027
8.2.1.2 Market size analysis, By Application, 2020-2027
8.2.1.3 Market size analysis, By Testing Type, 2020-2027
8.2.2 UK
8.2.2.1 Market size analysis, By Product, 2020-2027
8.2.2.2 Market size analysis, By Application, 2020-2027
8.2.2.3 Market size analysis, By Testing Type, 2020-2027
8.2.3 France
8.2.3.1 Market size analysis, By Product, 2020-2027
8.2.3.2 Market size analysis, By Application, 2020-2027
8.2.3.3 Market size analysis, By Testing Type, 2020-2027
8.2.4 Spain
8.2.4.1 Market size analysis, By Product, 2020-2027
8.2.4.2 Market size analysis, By Application, 2020-2027
8.2.4.3 Market size analysis, By Testing Type, 2020-2027
8.2.5 Italy
8.2.5.1 Market size analysis, By Product, 2020-2027
8.2.5.2 Market size analysis, By Application, 2020-2027
8.2.5.3 Market size analysis, By Testing Type, 2020-2027
8.2.6 Rest of Europe
8.2.6.1 Market size analysis, By Product, 2020-2027
8.2.6.2 Market size analysis, By Application, 2020-2027
8.2.6.3 Market size analysis, By Testing Type, 2020-2027
8.2.7 Research Dive Exclusive Insights
8.2.7.1 Market attractiveness
8.2.7.2 Competition heatmap
8.3 Asia-Pacific
8.3.1 China
8.3.1.1 Market size analysis, By Product, 2020-2027
8.3.1.2 Market size analysis, By Application, 2020-2027
8.3.1.3 Market size analysis, By Testing Type, 2020-2027
8.3.2 Japan
8.3.2.1 Market size analysis, By Product, 2020-2027
8.3.2.2 Market size analysis, By Application, 2020-2027
8.3.2.3 Market size analysis, By Testing Type, 2020-2027
8.3.3 India
8.3.3.1 Market size analysis, By Product, 2020-2027
8.3.3.2 Market size analysis, By Application, 2020-2027
8.3.3.3 Market size analysis, By Testing Type, 2020-2027
8.3.4 Australia
8.3.4.1 Market size analysis, By Product, 2020-2027
8.3.4.2 Market size analysis, By Application, 2020-2027
8.3.4.3 Market size analysis, By Testing Type, 2020-2027
8.3.5 South Korea
8.3.5.1 Market size analysis, By Product, 2020-2027
8.3.5.2 Market size analysis, By Application, 2020-2027
8.3.5.3 Market size analysis, By Testing Type, 2020-2027
8.3.6 Rest of Asia-Pacific
8.3.6.1 Market size analysis, By Product, 2020-2027
8.3.6.2 Market size analysis, By Application, 2020-2027
8.3.6.3 Market size analysis, By Testing Type, 2020-2027
8.3.7 Research Dive Exclusive Insights
8.3.7.1 Market attractiveness
8.3.7.2 Competition heatmap
8.4 LAMEA
8.4.1 Brazil
8.4.1.1 Market size analysis, By Product, 2020-2027
8.4.1.2 Market size analysis, By Application, 2020-2027
8.4.1.3 Market size analysis, By Testing Type, 2020-2027
8.4.2 Saudi Arabia
8.4.2.1 Market size analysis, By Product, 2020-2027
8.4.2.2 Market size analysis, By Application, 2020-2027
8.4.2.3 Market size analysis, By Testing Type, 2020-2027
8.4.3 UAE
8.4.3.1 Market size analysis, By Product, 2020-2027
8.4.3.2 Market size analysis, By Application, 2020-2027
8.4.3.3 Market size analysis, By Testing Type, 2020-2027
8.4.4 South Africa
8.4.4.1 Market size analysis, By Product, 2020-2027
8.4.4.2 Market size analysis, By Application, 2020-2027
8.4.4.3 Market size analysis, By Testing Type, 2020-2027
8.4.5 Rest of LAMEA
8.4.5.1 Market size analysis, By Product, 2020-2027
8.4.5.2 Market size analysis, By Application, 2020-2027
8.4.5.3 Market size analysis, By Testing Type, 2020-2027
8.4.6 Research Dive Exclusive Insights
8.4.6.1 Market attractiveness
8.4.6.2 Competition heatmap
9. Competitive Landscape
9.1 Top winning strategies, 2020-2027
9.1.1 By strategy
9.1.2 By year
9.2 Strategic overview
9.3 Market share analysis, 2020-2027
10. Company Profiles
10.1 Andersen Products, Inc.
10.1.1 Overview
10.1.2 Business segments
10.1.3 Product portfolio
10.1.4 Financial performance
10.1.5 Recent developments
10.1.6 SWOT analysis
10.2 C.R. Bard Medical
10.2.1 Overview
10.2.2 Business segments
10.2.3 Product portfolio
10.2.4 Financial performance
10.2.5 Recent developments
10.2.6 SWOT analysis
10.3 Bicakcilar A.S.
10.3.1 Overview
10.3.2 Business segments
10.3.3 Product portfolio
10.3.4 Financial performance
10.3.5 Recent developments
10.3.6 SWOT analysis
10.4 Cardinal Health
10.4.1 Overview
10.4.2 Business segments
10.4.3 Product portfolio
10.4.4 Financial performance
10.4.5 Recent developments
10.4.6 SWOT analysis
10.5 Degania Silicone Ltd.
10.5.1 Overview
10.5.2 Business segments
10.5.3 Product portfolio
10.5.4 Financial performance
10.5.5 Recent developments
10.5.6 SWOT analysis
10.6 Guangdong Baihe Medical Technology
10.6.1 Overview
10.6.2 Business segments
10.6.3 Product portfolio
10.6.4 Financial performance
10.6.5 Recent developments
10.6.6 SWOT analysis
10.7 Pacific Hospital Supply Co. Ltd.
10.7.1 Overview
10.7.2 Business segments
10.7.3 Product portfolio
10.7.4 Financial performance
10.7.5 Recent developments
10.7.6 SWOT analysis
10.8 Poly Medicure Limited
10.8.1 Overview
10.8.2 Business segments
10.8.3 Product portfolio
10.8.4 Financial performance
10.8.5 Recent developments
10.8.6 SWOT analysis
10.9 Rontis Medical
10.9.1 Overview
10.9.2 Business segments
10.9.3 Product portfolio
10.9.4 Financial performance
10.9.5 Recent developments
10.9.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
